Benjamin Solomon

468 total citations
30 papers, 286 citations indexed

About

Benjamin Solomon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Benjamin Solomon has authored 30 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Benjamin Solomon's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (6 papers) and Advanced Breast Cancer Therapies (5 papers). Benjamin Solomon is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (6 papers) and Advanced Breast Cancer Therapies (5 papers). Benjamin Solomon collaborates with scholars based in United States, Spain and Denmark. Benjamin Solomon's co-authors include Aminah Jatoi, James R. Cerhan, Tait D. Shanafelt, Susan L. Slager, Kari G. Rabe, Jerry D. Brewer, Neil E. Kay, Jonathan Moreira, Susan M. Schwager and Timothy G. Call and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Benjamin Solomon

24 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Solomon United States 10 111 93 88 78 50 30 286
Richard Mansour United States 9 152 1.4× 39 0.4× 71 0.8× 45 0.6× 38 0.8× 56 326
Offiong F. Ikpatt United States 10 176 1.6× 31 0.3× 31 0.4× 101 1.3× 91 1.8× 27 367
Nisreen Amayiri Jordan 11 39 0.4× 125 1.3× 38 0.4× 48 0.6× 40 0.8× 28 259
T.B. Johannesen Norway 3 128 1.2× 50 0.5× 45 0.5× 57 0.7× 24 0.5× 5 273
Gemma Osca‐Gelis Spain 7 192 1.7× 70 0.8× 31 0.4× 86 1.1× 21 0.4× 13 337
K.G. van der Hem Netherlands 8 119 1.1× 58 0.6× 26 0.3× 118 1.5× 12 0.2× 16 268
Christopher D. Watt United States 12 131 1.2× 64 0.7× 140 1.6× 50 0.6× 90 1.8× 25 456
Roar Sandvei Norway 13 89 0.8× 30 0.3× 40 0.5× 81 1.0× 70 1.4× 37 596
Monika Pogorzała Poland 12 53 0.5× 38 0.4× 138 1.6× 40 0.5× 32 0.6× 32 341
Paul J. Thurmes United States 7 184 1.7× 150 1.6× 230 2.6× 136 1.7× 32 0.6× 8 483

Countries citing papers authored by Benjamin Solomon

Since Specialization
Citations

This map shows the geographic impact of Benjamin Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Solomon more than expected).

Fields of papers citing papers by Benjamin Solomon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Solomon. The network helps show where Benjamin Solomon may publish in the future.

Co-authorship network of co-authors of Benjamin Solomon

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Solomon. A scholar is included among the top collaborators of Benjamin Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Solomon. Benjamin Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faltys, Martin, Marliese Alexander, Sagun Parakh, et al.. (2025). Second-line treatment strategies and clinical outcomes after progression on chemoimmunotherapy in extensive-stage small-cell lung cancer. Lung Cancer. 209. 108786–108786.
2.
Girard, Nicolas, Julia Bar, Daniel C. Christoph, et al.. (2025). 190P: Real-world 5-year survival outcomes with durvalumab (D) after chemoradiotherapy (CRT) in unresectable, stage III NSCLC (urNSCLC): Final data extraction from PACIFIC-R. Journal of Thoracic Oncology. 20(3). S127–S128.
3.
Donaldson, Andrea, et al.. (2024). An exploration of frontline health professional's current understanding of non‐fatal strangulation. Journal of Advanced Nursing. 80(12). 5090–5101.
4.
Harvey, Christopher, Tien K. Khoo, Bailin Zhang, et al.. (2023). MA17.05 Real World Outcomes of Immunotherapy (IO) for Pleural MESOthelioma in Australia - RIOMeso. Journal of Thoracic Oncology. 18(11). S163–S163. 1 indexed citations
5.
Tan, Daniel Shao-Weng, Shivaani Kummar, Jyoti D. Patel, et al.. (2023). Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer.. Journal of Clinical Oncology. 41(16_suppl). 9056–9056. 3 indexed citations
6.
Drilon, Alexander, Shivaani Kummar, Daniel Shao-Weng Tan, et al.. (2022). Updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer.. Journal of Clinical Oncology. 40(16_suppl). 9024–9024. 3 indexed citations
7.
Sicklick, Jason K., Shumei Kato, Ryosuke Okamura, et al.. (2021). Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study. Genome Medicine. 13(1). 155–155. 62 indexed citations
8.
Tan, Daniel S.W., Jay Patel, Ulrik Lassen, et al.. (2021). MA11.09 Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer. Journal of Thoracic Oncology. 16(3). S176–S176. 2 indexed citations
9.
Jelin, Angie C., Nara Sobreira, Elizabeth Wohler, et al.. (2020). The utility of exome sequencing for fetal pleural effusions. Prenatal Diagnosis. 40(5). 590–595. 10 indexed citations
10.
Drilon, Alexander, Víctor Moreno, Jyoti D. Patel, et al.. (2020). 1289P Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer. Annals of Oncology. 31. S834–S834. 5 indexed citations
11.
Patel, Jyoti D., Anna F. Farago, David S. Hong, et al.. (2020). CTNI-04. ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES. Neuro-Oncology. 22(Supplement_2). ii41–ii42. 1 indexed citations
12.
Drilon, Alexander, Anna F. Farago, Daniel Shao-Weng Tan, et al.. (2020). Activity and safety of larotrectinib in adult patients with TRK fusion cancer: An expanded data set.. Journal of Clinical Oncology. 38(15_suppl). 3610–3610. 10 indexed citations
13.
Lim, Annette M., Benjamin Solomon, & Danny Rischin. (2015). Molecular insights influencing the management of head and neck cancers. Cancer Forum. 39(1). 29.
14.
Solomon, Benjamin, Kari G. Chaffee, Jonathan Moreira, et al.. (2015). Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis. Leukemia. 30(2). 331–336. 35 indexed citations
15.
Solomon, Benjamin, Kari G. Rabe, Susan L. Slager, et al.. (2013). Overall and Cancer-Specific Survival of Patients With Breast, Colon, Kidney, and Lung Cancers With and Without Chronic Lymphocytic Leukemia: A SEER Population-Based Study. Journal of Clinical Oncology. 31(7). 930–937. 50 indexed citations
16.
Reddy, Chandan G., Michelle L. Mauermann, Benjamin Solomon, et al.. (2012). Neuroleukemiosis: an unusual cause of peripheral neuropathy. Leukemia & lymphoma. 53(12). 2405–2411. 24 indexed citations
17.
Solomon, Benjamin & Aminah Jatoi. (2008). Rash from EGFR inhibitors: Opportunities and challenges for palliation. Current Oncology Reports. 10(4). 304–308. 16 indexed citations
18.
Solomon, Benjamin. (1997). Return to the First Image. Journal of Peace Research. 34(3). 249–255. 1 indexed citations
19.
Solomon, Benjamin. (1956). Dimensions of Union Growth 1900 – 1950. Industrial and Labor Relations Review. 9(4). 544–561. 2 indexed citations
20.
Solomon, Benjamin, et al.. (1956). Nonfactory Unionism and Labor Relations.. Industrial and Labor Relations Review. 9(4). 672–672. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Mansour Breakdown of academic impact, for papers by Offiong F. Ikpatt Breakdown of academic impact, for papers by Nisreen Amayiri Breakdown of academic impact, for papers by T.B. Johannesen Breakdown of academic impact, for papers by Gemma Osca‐Gelis Breakdown of academic impact, for papers by K.G. van der Hem Breakdown of academic impact, for papers by Christopher D. Watt Breakdown of academic impact, for papers by Roar Sandvei Breakdown of academic impact, for papers by Monika Pogorzała Breakdown of academic impact, for papers by Paul J. Thurmes
Rankless by CCL
2026